Green Biologics completes investment round

Green Biologics Limited, a technology provider for bio-butanol production, has announced the completion of an investment round of £4.9m to roll out its technology and commercialisation plans.

The round was led by Capricorn Venture Partners, a new investor in GBL through its Capricorn Cleantech Fund, and included participation by all GBL’s existing institutional investors – Morningside Ventures, Carbon Trust Investment Limited and Oxford Capital Partners – as well as by management and founder investors.